0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology API Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-21G18093
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology API Market Research Report 2024
BUY CHAPTERS

Global Oncology API Market Research Report 2024

Code: QYRE-Auto-21G18093
Report
August 2024
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oncology API Market Size

The global Oncology API market was valued at US$ 2000 million in 2023 and is anticipated to reach US$ 3212 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.

Oncology API Market

Oncology API Market

Oncology API (Active Pharmaceutical Ingredient) refers to the active substances used in the formulation of drugs specifically for the treatment of cancer. These APIs are used to target and treat various types of cancer through different mechanisms of action. They include chemotherapy agents, targeted therapies, hormonal treatments, and immunotherapies, each with specific mechanisms of action. The development, manufacturing, and regulatory oversight of these APIs are critical to ensuring their safety, efficacy, and availability for cancer patients.
North American market for Oncology API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oncology API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oncology API include Olon Group, PolyPeptide, Glenmark Life Sciences, Sterling, Neopharma, Concord Biotech, Eisai Pharmaceuticals, Aspen API, Dr. Reddy's, CordenPharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology API.
The Oncology API market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Oncology API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oncology API Market Report

Report Metric Details
Report Name Oncology API Market
Accounted market size in 2023 US$ 2000 million
Forecasted market size in 2030 US$ 3212 million
CAGR 7.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Olon Group, PolyPeptide, Glenmark Life Sciences, Sterling, Neopharma, Concord Biotech, Eisai Pharmaceuticals, Aspen API, Dr. Reddy's, CordenPharma, Natco, PROCOS SPA, Biocon, Shivalik Rasayan, Kekule Pharma, Aenova, GLS Pharma, Suanfarma, Fresenius Kabi Oncology, Hetero, Bachem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oncology API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oncology API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Oncology API Market growing?

Ans: The Oncology API Market witnessing a CAGR of 7.0% during the forecast period 2024-2030.

What is the Oncology API Market size in 2030?

Ans: The Oncology API Market size in 2030 will be US$ 3212 million.

Who are the main players in the Oncology API Market report?

Ans: The main players in the Oncology API Market are Olon Group, PolyPeptide, Glenmark Life Sciences, Sterling, Neopharma, Concord Biotech, Eisai Pharmaceuticals, Aspen API, Dr. Reddy's, CordenPharma, Natco, PROCOS SPA, Biocon, Shivalik Rasayan, Kekule Pharma, Aenova, GLS Pharma, Suanfarma, Fresenius Kabi Oncology, Hetero, Bachem

What are the Application segmentation covered in the Oncology API Market report?

Ans: The Applications covered in the Oncology API Market report are Chemotherapy, Targeted Therapy, Immunotherapy, Others

What are the Type segmentation covered in the Oncology API Market report?

Ans: The Types covered in the Oncology API Market report are Alkylating Agents, Antimetabolites, Others

Recommended Reports

Oncology API Markets

Cancer Treatment Drugs

API Market Derivatives

1 Oncology API Market Overview
1.1 Product Definition
1.2 Oncology API by Type
1.2.1 Global Oncology API Market Value Comparison by Type (2024-2030)
1.2.2 Alkylating Agents
1.2.3 Antimetabolites
1.2.4 Others
1.3 Oncology API by Application
1.3.1 Global Oncology API Market Value by Application (2024-2030)
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy
1.3.5 Others
1.4 Global Oncology API Market Size Estimates and Forecasts
1.4.1 Global Oncology API Revenue 2019-2030
1.4.2 Global Oncology API Sales 2019-2030
1.4.3 Global Oncology API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oncology API Market Competition by Manufacturers
2.1 Global Oncology API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oncology API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oncology API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Oncology API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oncology API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology API, Product Type & Application
2.7 Global Key Manufacturers of Oncology API, Date of Enter into This Industry
2.8 Global Oncology API Market Competitive Situation and Trends
2.8.1 Global Oncology API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oncology API Players Market Share by Revenue
2.8.3 Global Oncology API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oncology API Market Scenario by Region
3.1 Global Oncology API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oncology API Sales by Region: 2019-2030
3.2.1 Global Oncology API Sales by Region: 2019-2024
3.2.2 Global Oncology API Sales by Region: 2025-2030
3.3 Global Oncology API Revenue by Region: 2019-2030
3.3.1 Global Oncology API Revenue by Region: 2019-2024
3.3.2 Global Oncology API Revenue by Region: 2025-2030
3.4 North America Oncology API Market Facts & Figures by Country
3.4.1 North America Oncology API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oncology API Sales by Country (2019-2030)
3.4.3 North America Oncology API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oncology API Market Facts & Figures by Country
3.5.1 Europe Oncology API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oncology API Sales by Country (2019-2030)
3.5.3 Europe Oncology API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncology API Market Facts & Figures by Region
3.6.1 Asia Pacific Oncology API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oncology API Sales by Region (2019-2030)
3.6.3 Asia Pacific Oncology API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oncology API Market Facts & Figures by Country
3.7.1 Latin America Oncology API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oncology API Sales by Country (2019-2030)
3.7.3 Latin America Oncology API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oncology API Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncology API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oncology API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oncology API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oncology API Sales by Type (2019-2030)
4.1.1 Global Oncology API Sales by Type (2019-2024)
4.1.2 Global Oncology API Sales by Type (2025-2030)
4.1.3 Global Oncology API Sales Market Share by Type (2019-2030)
4.2 Global Oncology API Revenue by Type (2019-2030)
4.2.1 Global Oncology API Revenue by Type (2019-2024)
4.2.2 Global Oncology API Revenue by Type (2025-2030)
4.2.3 Global Oncology API Revenue Market Share by Type (2019-2030)
4.3 Global Oncology API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oncology API Sales by Application (2019-2030)
5.1.1 Global Oncology API Sales by Application (2019-2024)
5.1.2 Global Oncology API Sales by Application (2025-2030)
5.1.3 Global Oncology API Sales Market Share by Application (2019-2030)
5.2 Global Oncology API Revenue by Application (2019-2030)
5.2.1 Global Oncology API Revenue by Application (2019-2024)
5.2.2 Global Oncology API Revenue by Application (2025-2030)
5.2.3 Global Oncology API Revenue Market Share by Application (2019-2030)
5.3 Global Oncology API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Olon Group
6.1.1 Olon Group Company Information
6.1.2 Olon Group Description and Business Overview
6.1.3 Olon Group Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Olon Group Oncology API Product Portfolio
6.1.5 Olon Group Recent Developments/Updates
6.2 PolyPeptide
6.2.1 PolyPeptide Company Information
6.2.2 PolyPeptide Description and Business Overview
6.2.3 PolyPeptide Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 PolyPeptide Oncology API Product Portfolio
6.2.5 PolyPeptide Recent Developments/Updates
6.3 Glenmark Life Sciences
6.3.1 Glenmark Life Sciences Company Information
6.3.2 Glenmark Life Sciences Description and Business Overview
6.3.3 Glenmark Life Sciences Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glenmark Life Sciences Oncology API Product Portfolio
6.3.5 Glenmark Life Sciences Recent Developments/Updates
6.4 Sterling
6.4.1 Sterling Company Information
6.4.2 Sterling Description and Business Overview
6.4.3 Sterling Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sterling Oncology API Product Portfolio
6.4.5 Sterling Recent Developments/Updates
6.5 Neopharma
6.5.1 Neopharma Company Information
6.5.2 Neopharma Description and Business Overview
6.5.3 Neopharma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Neopharma Oncology API Product Portfolio
6.5.5 Neopharma Recent Developments/Updates
6.6 Concord Biotech
6.6.1 Concord Biotech Company Information
6.6.2 Concord Biotech Description and Business Overview
6.6.3 Concord Biotech Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Concord Biotech Oncology API Product Portfolio
6.6.5 Concord Biotech Recent Developments/Updates
6.7 Eisai Pharmaceuticals
6.7.1 Eisai Pharmaceuticals Company Information
6.7.2 Eisai Pharmaceuticals Description and Business Overview
6.7.3 Eisai Pharmaceuticals Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Eisai Pharmaceuticals Oncology API Product Portfolio
6.7.5 Eisai Pharmaceuticals Recent Developments/Updates
6.8 Aspen API
6.8.1 Aspen API Company Information
6.8.2 Aspen API Description and Business Overview
6.8.3 Aspen API Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aspen API Oncology API Product Portfolio
6.8.5 Aspen API Recent Developments/Updates
6.9 Dr. Reddy's
6.9.1 Dr. Reddy's Company Information
6.9.2 Dr. Reddy's Description and Business Overview
6.9.3 Dr. Reddy's Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dr. Reddy's Oncology API Product Portfolio
6.9.5 Dr. Reddy's Recent Developments/Updates
6.10 CordenPharma
6.10.1 CordenPharma Company Information
6.10.2 CordenPharma Description and Business Overview
6.10.3 CordenPharma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CordenPharma Oncology API Product Portfolio
6.10.5 CordenPharma Recent Developments/Updates
6.11 Natco
6.11.1 Natco Company Information
6.11.2 Natco Description and Business Overview
6.11.3 Natco Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Natco Oncology API Product Portfolio
6.11.5 Natco Recent Developments/Updates
6.12 PROCOS SPA
6.12.1 PROCOS SPA Company Information
6.12.2 PROCOS SPA Description and Business Overview
6.12.3 PROCOS SPA Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 PROCOS SPA Oncology API Product Portfolio
6.12.5 PROCOS SPA Recent Developments/Updates
6.13 Biocon
6.13.1 Biocon Company Information
6.13.2 Biocon Description and Business Overview
6.13.3 Biocon Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Biocon Oncology API Product Portfolio
6.13.5 Biocon Recent Developments/Updates
6.14 Shivalik Rasayan
6.14.1 Shivalik Rasayan Company Information
6.14.2 Shivalik Rasayan Description and Business Overview
6.14.3 Shivalik Rasayan Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shivalik Rasayan Oncology API Product Portfolio
6.14.5 Shivalik Rasayan Recent Developments/Updates
6.15 Kekule Pharma
6.15.1 Kekule Pharma Company Information
6.15.2 Kekule Pharma Description and Business Overview
6.15.3 Kekule Pharma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Kekule Pharma Oncology API Product Portfolio
6.15.5 Kekule Pharma Recent Developments/Updates
6.16 Aenova
6.16.1 Aenova Company Information
6.16.2 Aenova Description and Business Overview
6.16.3 Aenova Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Aenova Oncology API Product Portfolio
6.16.5 Aenova Recent Developments/Updates
6.17 GLS Pharma
6.17.1 GLS Pharma Company Information
6.17.2 GLS Pharma Description and Business Overview
6.17.3 GLS Pharma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.17.4 GLS Pharma Oncology API Product Portfolio
6.17.5 GLS Pharma Recent Developments/Updates
6.18 Suanfarma
6.18.1 Suanfarma Company Information
6.18.2 Suanfarma Description and Business Overview
6.18.3 Suanfarma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Suanfarma Oncology API Product Portfolio
6.18.5 Suanfarma Recent Developments/Updates
6.19 Fresenius Kabi Oncology
6.19.1 Fresenius Kabi Oncology Company Information
6.19.2 Fresenius Kabi Oncology Description and Business Overview
6.19.3 Fresenius Kabi Oncology Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Fresenius Kabi Oncology Oncology API Product Portfolio
6.19.5 Fresenius Kabi Oncology Recent Developments/Updates
6.20 Hetero
6.20.1 Hetero Company Information
6.20.2 Hetero Description and Business Overview
6.20.3 Hetero Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Hetero Oncology API Product Portfolio
6.20.5 Hetero Recent Developments/Updates
6.21 Bachem
6.21.1 Bachem Company Information
6.21.2 Bachem Description and Business Overview
6.21.3 Bachem Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Bachem Oncology API Product Portfolio
6.21.5 Bachem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncology API Industry Chain Analysis
7.2 Oncology API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncology API Production Mode & Process
7.4 Oncology API Sales and Marketing
7.4.1 Oncology API Sales Channels
7.4.2 Oncology API Distributors
7.5 Oncology API Customers
8 Oncology API Market Dynamics
8.1 Oncology API Industry Trends
8.2 Oncology API Market Drivers
8.3 Oncology API Market Challenges
8.4 Oncology API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oncology API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Oncology API Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Oncology API Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Oncology API Sales (kg) of Key Manufacturers (2019-2024)
 Table 5. Global Oncology API Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Oncology API Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Oncology API Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Oncology API Average Price (US$/kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Oncology API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oncology API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oncology API, Product Type & Application
 Table 12. Global Key Manufacturers of Oncology API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oncology API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology API as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oncology API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Oncology API Sales by Region (2019-2024) & (kg)
 Table 18. Global Oncology API Sales Market Share by Region (2019-2024)
 Table 19. Global Oncology API Sales by Region (2025-2030) & (kg)
 Table 20. Global Oncology API Sales Market Share by Region (2025-2030)
 Table 21. Global Oncology API Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Oncology API Revenue Market Share by Region (2019-2024)
 Table 23. Global Oncology API Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Oncology API Revenue Market Share by Region (2025-2030)
 Table 25. North America Oncology API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Oncology API Sales by Country (2019-2024) & (kg)
 Table 27. North America Oncology API Sales by Country (2025-2030) & (kg)
 Table 28. North America Oncology API Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Oncology API Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Oncology API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Oncology API Sales by Country (2019-2024) & (kg)
 Table 32. Europe Oncology API Sales by Country (2025-2030) & (kg)
 Table 33. Europe Oncology API Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Oncology API Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Oncology API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Oncology API Sales by Region (2019-2024) & (kg)
 Table 37. Asia Pacific Oncology API Sales by Region (2025-2030) & (kg)
 Table 38. Asia Pacific Oncology API Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Oncology API Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Oncology API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Oncology API Sales by Country (2019-2024) & (kg)
 Table 42. Latin America Oncology API Sales by Country (2025-2030) & (kg)
 Table 43. Latin America Oncology API Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Oncology API Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Oncology API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Oncology API Sales by Country (2019-2024) & (kg)
 Table 47. Middle East and Africa Oncology API Sales by Country (2025-2030) & (kg)
 Table 48. Middle East and Africa Oncology API Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Oncology API Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Oncology API Sales (kg) by Type (2019-2024)
 Table 51. Global Oncology API Sales (kg) by Type (2025-2030)
 Table 52. Global Oncology API Sales Market Share by Type (2019-2024)
 Table 53. Global Oncology API Sales Market Share by Type (2025-2030)
 Table 54. Global Oncology API Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Oncology API Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Oncology API Revenue Market Share by Type (2019-2024)
 Table 57. Global Oncology API Revenue Market Share by Type (2025-2030)
 Table 58. Global Oncology API Price (US$/kg) by Type (2019-2024)
 Table 59. Global Oncology API Price (US$/kg) by Type (2025-2030)
 Table 60. Global Oncology API Sales (kg) by Application (2019-2024)
 Table 61. Global Oncology API Sales (kg) by Application (2025-2030)
 Table 62. Global Oncology API Sales Market Share by Application (2019-2024)
 Table 63. Global Oncology API Sales Market Share by Application (2025-2030)
 Table 64. Global Oncology API Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Oncology API Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Oncology API Revenue Market Share by Application (2019-2024)
 Table 67. Global Oncology API Revenue Market Share by Application (2025-2030)
 Table 68. Global Oncology API Price (US$/kg) by Application (2019-2024)
 Table 69. Global Oncology API Price (US$/kg) by Application (2025-2030)
 Table 70. Olon Group Company Information
 Table 71. Olon Group Description and Business Overview
 Table 72. Olon Group Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 73. Olon Group Oncology API Product
 Table 74. Olon Group Recent Developments/Updates
 Table 75. PolyPeptide Company Information
 Table 76. PolyPeptide Description and Business Overview
 Table 77. PolyPeptide Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 78. PolyPeptide Oncology API Product
 Table 79. PolyPeptide Recent Developments/Updates
 Table 80. Glenmark Life Sciences Company Information
 Table 81. Glenmark Life Sciences Description and Business Overview
 Table 82. Glenmark Life Sciences Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 83. Glenmark Life Sciences Oncology API Product
 Table 84. Glenmark Life Sciences Recent Developments/Updates
 Table 85. Sterling Company Information
 Table 86. Sterling Description and Business Overview
 Table 87. Sterling Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 88. Sterling Oncology API Product
 Table 89. Sterling Recent Developments/Updates
 Table 90. Neopharma Company Information
 Table 91. Neopharma Description and Business Overview
 Table 92. Neopharma Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 93. Neopharma Oncology API Product
 Table 94. Neopharma Recent Developments/Updates
 Table 95. Concord Biotech Company Information
 Table 96. Concord Biotech Description and Business Overview
 Table 97. Concord Biotech Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 98. Concord Biotech Oncology API Product
 Table 99. Concord Biotech Recent Developments/Updates
 Table 100. Eisai Pharmaceuticals Company Information
 Table 101. Eisai Pharmaceuticals Description and Business Overview
 Table 102. Eisai Pharmaceuticals Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 103. Eisai Pharmaceuticals Oncology API Product
 Table 104. Eisai Pharmaceuticals Recent Developments/Updates
 Table 105. Aspen API Company Information
 Table 106. Aspen API Description and Business Overview
 Table 107. Aspen API Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 108. Aspen API Oncology API Product
 Table 109. Aspen API Recent Developments/Updates
 Table 110. Dr. Reddy's Company Information
 Table 111. Dr. Reddy's Description and Business Overview
 Table 112. Dr. Reddy's Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 113. Dr. Reddy's Oncology API Product
 Table 114. Dr. Reddy's Recent Developments/Updates
 Table 115. CordenPharma Company Information
 Table 116. CordenPharma Description and Business Overview
 Table 117. CordenPharma Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 118. CordenPharma Oncology API Product
 Table 119. CordenPharma Recent Developments/Updates
 Table 120. Natco Company Information
 Table 121. Natco Description and Business Overview
 Table 122. Natco Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 123. Natco Oncology API Product
 Table 124. Natco Recent Developments/Updates
 Table 125. PROCOS SPA Company Information
 Table 126. PROCOS SPA Description and Business Overview
 Table 127. PROCOS SPA Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 128. PROCOS SPA Oncology API Product
 Table 129. PROCOS SPA Recent Developments/Updates
 Table 130. Biocon Company Information
 Table 131. Biocon Description and Business Overview
 Table 132. Biocon Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 133. Biocon Oncology API Product
 Table 134. Biocon Recent Developments/Updates
 Table 135. Shivalik Rasayan Company Information
 Table 136. Shivalik Rasayan Description and Business Overview
 Table 137. Shivalik Rasayan Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 138. Shivalik Rasayan Oncology API Product
 Table 139. Shivalik Rasayan Recent Developments/Updates
 Table 140. Kekule Pharma Company Information
 Table 141. Kekule Pharma Description and Business Overview
 Table 142. Kekule Pharma Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 143. Kekule Pharma Oncology API Product
 Table 144. Kekule Pharma Recent Developments/Updates
 Table 145. Aenova Company Information
 Table 146. Aenova Description and Business Overview
 Table 147. Aenova Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 148. Aenova Oncology API Product
 Table 149. Aenova Recent Developments/Updates
 Table 150. GLS Pharma Company Information
 Table 151. GLS Pharma Description and Business Overview
 Table 152. GLS Pharma Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 153. GLS Pharma Oncology API Product
 Table 154. GLS Pharma Recent Developments/Updates
 Table 155. Suanfarma Company Information
 Table 156. Suanfarma Description and Business Overview
 Table 157. Suanfarma Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 158. Suanfarma Oncology API Product
 Table 159. Suanfarma Recent Developments/Updates
 Table 160. Fresenius Kabi Oncology Company Information
 Table 161. Fresenius Kabi Oncology Description and Business Overview
 Table 162. Fresenius Kabi Oncology Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 163. Fresenius Kabi Oncology Oncology API Product
 Table 164. Fresenius Kabi Oncology Recent Developments/Updates
 Table 165. Hetero Company Information
 Table 166. Hetero Description and Business Overview
 Table 167. Hetero Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 168. Hetero Oncology API Product
 Table 169. Hetero Recent Developments/Updates
 Table 170. Bachem Company Information
 Table 171. Bachem Description and Business Overview
 Table 172. Bachem Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 173. Bachem Oncology API Product
 Table 174. Bachem Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Oncology API Distributors List
 Table 178. Oncology API Customers List
 Table 179. Oncology API Market Trends
 Table 180. Oncology API Market Drivers
 Table 181. Oncology API Market Challenges
 Table 182. Oncology API Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oncology API
 Figure 2. Global Oncology API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Oncology API Market Share by Type: 2023 & 2030
 Figure 4. Alkylating Agents Product Picture
 Figure 5. Antimetabolites Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Oncology API Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Oncology API Market Share by Application: 2023 & 2030
 Figure 9. Chemotherapy
 Figure 10. Targeted Therapy
 Figure 11. Immunotherapy
 Figure 12. Others
 Figure 13. Global Oncology API Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Oncology API Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Oncology API Sales (2019-2030) & (kg)
 Figure 16. Global Oncology API Average Price (US$/kg) & (2019-2030)
 Figure 17. Oncology API Report Years Considered
 Figure 18. Oncology API Sales Share by Manufacturers in 2023
 Figure 19. Global Oncology API Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Oncology API Players: Market Share by Revenue in Oncology API in 2023
 Figure 21. Oncology API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Oncology API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Oncology API Sales Market Share by Country (2019-2030)
 Figure 24. North America Oncology API Revenue Market Share by Country (2019-2030)
 Figure 25. United States Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Oncology API Sales Market Share by Country (2019-2030)
 Figure 28. Europe Oncology API Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Oncology API Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Oncology API Revenue Market Share by Region (2019-2030)
 Figure 36. China Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Oncology API Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Oncology API Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Oncology API Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Oncology API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Oncology API by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Oncology API by Type (2019-2030)
 Figure 55. Global Oncology API Price (US$/kg) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Oncology API by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Oncology API by Application (2019-2030)
 Figure 58. Global Oncology API Price (US$/kg) by Application (2019-2030)
 Figure 59. Oncology API Value Chain
 Figure 60. Oncology API Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String